Cadisegliatin 800 mg BID

Drug identity checked against registry records

Also recorded as TTP399

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesNCT06334133vTv TherapeuticsPhase 3Active not recruiting2027-04Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.